+1 347 708 0418
The Nasopharyngeal Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nasopharyngeal Cancer size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Nasopharyngeal Cancer market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nasopharyngeal Cancer market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Surgery
Radiation
Chemotherapy
Market segment by Application, can be divided into
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers
Market segment by players, this report covers
Roche
Sanofi
Merck
Cyclacel Pharmaceuticals
Celgene
BioDiem
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Nasopharyngeal Cancer product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Nasopharyngeal Cancer, with revenue, gross margin and global market share of Nasopharyngeal Cancer from 2019 to 2021.
Chapter 3, the Nasopharyngeal Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Nasopharyngeal Cancer market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Nasopharyngeal Cancer research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Nasopharyngeal Cancer
1.2 Classification of Nasopharyngeal Cancer by Type
1.2.1 Overview: Global Nasopharyngeal Cancer Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Nasopharyngeal Cancer Revenue Market Share by Type in 2020
1.2.3 Surgery
1.2.4 Radiation
1.2.5 Chemotherapy
1.3 Global Nasopharyngeal Cancer Market by Application
1.3.1 Overview: Global Nasopharyngeal Cancer Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Treatment and Rehabilitation Centers
1.4 Global Nasopharyngeal Cancer Market Size & Forecast
1.5 Global Nasopharyngeal Cancer Market Size and Forecast by Region
1.5.1 Global Nasopharyngeal Cancer Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Nasopharyngeal Cancer Market Size by Region, (2016-2021)
1.5.3 North America Nasopharyngeal Cancer Market Size and Prospect (2016-2026)
1.5.4 Europe Nasopharyngeal Cancer Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Nasopharyngeal Cancer Market Size and Prospect (2016-2026)
1.5.6 South America Nasopharyngeal Cancer Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Nasopharyngeal Cancer Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Nasopharyngeal Cancer Market Drivers
1.6.2 Nasopharyngeal Cancer Market Restraints
1.6.3 Nasopharyngeal Cancer Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Nasopharyngeal Cancer Product and Solutions
2.1.4 Roche Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Nasopharyngeal Cancer Product and Solutions
2.2.4 Sanofi Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Nasopharyngeal Cancer Product and Solutions
2.3.4 Merck Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 Cyclacel Pharmaceuticals
2.4.1 Cyclacel Pharmaceuticals Details
2.4.2 Cyclacel Pharmaceuticals Major Business
2.4.3 Cyclacel Pharmaceuticals Nasopharyngeal Cancer Product and Solutions
2.4.4 Cyclacel Pharmaceuticals Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Cyclacel Pharmaceuticals Recent Developments and Future Plans
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Nasopharyngeal Cancer Product and Solutions
2.5.4 Celgene Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Celgene Recent Developments and Future Plans
2.6 BioDiem
2.6.1 BioDiem Details
2.6.2 BioDiem Major Business
2.6.3 BioDiem Nasopharyngeal Cancer Product and Solutions
2.6.4 BioDiem Nasopharyngeal Cancer Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 BioDiem Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nasopharyngeal Cancer Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Nasopharyngeal Cancer Players Market Share
3.2.2 Top 10 Nasopharyngeal Cancer Players Market Share
3.2.3 Market Competition Trend
3.3 Nasopharyngeal Cancer Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Nasopharyngeal Cancer Revenue and Market Share by Type (2016-2021)
4.2 Global Nasopharyngeal Cancer Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Nasopharyngeal Cancer Revenue Market Share by Application (2016-2021)
5.2 Nasopharyngeal Cancer Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Nasopharyngeal Cancer Revenue by Type (2016-2026)
6.2 North America Nasopharyngeal Cancer Revenue by Application (2016-2026)
6.3 North America Nasopharyngeal Cancer Market Size by Country
6.3.1 North America Nasopharyngeal Cancer Revenue by Country (2016-2026)
6.3.2 United States Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
6.3.3 Canada Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
6.3.4 Mexico Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Nasopharyngeal Cancer Revenue by Type (2016-2026)
7.2 Europe Nasopharyngeal Cancer Revenue by Application (2016-2026)
7.3 Europe Nasopharyngeal Cancer Market Size by Country
7.3.1 Europe Nasopharyngeal Cancer Revenue by Country (2016-2026)
7.3.2 Germany Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
7.3.3 France Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
7.3.5 Russia Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
7.3.6 Italy Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Nasopharyngeal Cancer Revenue by Type (2016-2026)
8.2 Asia-Pacific Nasopharyngeal Cancer Revenue by Application (2016-2026)
8.3 Asia-Pacific Nasopharyngeal Cancer Market Size by Region
8.3.1 Asia-Pacific Nasopharyngeal Cancer Revenue by Region (2016-2026)
8.3.2 China Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
8.3.3 Japan Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
8.3.4 South Korea Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
8.3.5 India Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
8.3.7 Australia Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Nasopharyngeal Cancer Revenue by Type (2016-2026)
9.2 South America Nasopharyngeal Cancer Revenue by Application (2016-2026)
9.3 South America Nasopharyngeal Cancer Market Size by Country
9.3.1 South America Nasopharyngeal Cancer Revenue by Country (2016-2026)
9.3.2 Brazil Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
9.3.3 Argentina Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Nasopharyngeal Cancer Revenue by Type (2016-2026)
10.2 Middle East & Africa Nasopharyngeal Cancer Revenue by Application (2016-2026)
10.3 Middle East & Africa Nasopharyngeal Cancer Market Size by Country
10.3.1 Middle East & Africa Nasopharyngeal Cancer Revenue by Country (2016-2026)
10.3.2 Turkey Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
10.3.4 UAE Nasopharyngeal Cancer Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Nasopharyngeal Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Nasopharyngeal Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Nasopharyngeal Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Nasopharyngeal Cancer Revenue (USD Million) by Region (2016-2021)
Table 5. Global Nasopharyngeal Cancer Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Nasopharyngeal Cancer Product and Solutions
Table 9. Roche Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Nasopharyngeal Cancer Product and Solutions
Table 13. Sanofi Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Nasopharyngeal Cancer Product and Solutions
Table 17. Merck Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Cyclacel Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Cyclacel Pharmaceuticals Major Business
Table 20. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Product and Solutions
Table 21. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Celgene Corporate Information, Head Office, and Major Competitors
Table 23. Celgene Major Business
Table 24. Celgene Nasopharyngeal Cancer Product and Solutions
Table 25. Celgene Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. BioDiem Corporate Information, Head Office, and Major Competitors
Table 27. BioDiem Major Business
Table 28. BioDiem Nasopharyngeal Cancer Product and Solutions
Table 29. BioDiem Nasopharyngeal Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Nasopharyngeal Cancer Revenue (USD Million) by Players (2019-2021)
Table 31. Global Nasopharyngeal Cancer Revenue Share by Players (2019-2021)
Table 32. Breakdown of Nasopharyngeal Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Nasopharyngeal Cancer Players Head Office, Products and Services Provided
Table 34. Nasopharyngeal Cancer Mergers & Acquisitions in the Past Five Years
Table 35. Nasopharyngeal Cancer New Entrants and Expansion Plans
Table 36. Global Nasopharyngeal Cancer Revenue (USD Million) by Type (2016-2021)
Table 37. Global Nasopharyngeal Cancer Revenue Share by Type (2016-2021)
Table 38. Global Nasopharyngeal Cancer Revenue Forecast by Type (2021-2026)
Table 39. Global Nasopharyngeal Cancer Revenue by Application (2016-2021)
Table 40. Global Nasopharyngeal Cancer Revenue Forecast by Application (2021-2026)
Table 41. North America Nasopharyngeal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Nasopharyngeal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Nasopharyngeal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Nasopharyngeal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Nasopharyngeal Cancer Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Nasopharyngeal Cancer Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Nasopharyngeal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Nasopharyngeal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Nasopharyngeal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Nasopharyngeal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Nasopharyngeal Cancer Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Nasopharyngeal Cancer Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Nasopharyngeal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Nasopharyngeal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Nasopharyngeal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Nasopharyngeal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Nasopharyngeal Cancer Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Nasopharyngeal Cancer Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Nasopharyngeal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Nasopharyngeal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Nasopharyngeal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Nasopharyngeal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Nasopharyngeal Cancer Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Nasopharyngeal Cancer Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Nasopharyngeal Cancer Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Nasopharyngeal Cancer Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Nasopharyngeal Cancer Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Nasopharyngeal Cancer Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Nasopharyngeal Cancer Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Nasopharyngeal Cancer Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Nasopharyngeal Cancer Picture
Figure 2. Global Nasopharyngeal Cancer Revenue Market Share by Type in 2020
Figure 3. Surgery
Figure 4. Radiation
Figure 5. Chemotherapy
Figure 6. Nasopharyngeal Cancer Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Cancer Treatment and Rehabilitation Centers Picture
Figure 10. Global Nasopharyngeal Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Nasopharyngeal Cancer Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Nasopharyngeal Cancer Revenue Market Share by Region (2016-2026)
Figure 13. Global Nasopharyngeal Cancer Revenue Market Share by Region in 2020
Figure 14. North America Nasopharyngeal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Nasopharyngeal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Nasopharyngeal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Nasopharyngeal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Nasopharyngeal Cancer Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Nasopharyngeal Cancer Market Drivers
Figure 20. Nasopharyngeal Cancer Market Restraints
Figure 21. Nasopharyngeal Cancer Market Trends
Figure 22. Roche Recent Developments and Future Plans
Figure 23. Sanofi Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Cyclacel Pharmaceuticals Recent Developments and Future Plans
Figure 26. Celgene Recent Developments and Future Plans
Figure 27. BioDiem Recent Developments and Future Plans
Figure 28. Global Nasopharyngeal Cancer Revenue Share by Players in 2020
Figure 29. Nasopharyngeal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Nasopharyngeal Cancer Revenue Market Share in 2020
Figure 31. Global Top 10 Players Nasopharyngeal Cancer Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Nasopharyngeal Cancer Revenue Share by Type in 2020
Figure 34. Global Nasopharyngeal Cancer Market Share Forecast by Type (2021-2026)
Figure 35. Global Nasopharyngeal Cancer Revenue Share by Application in 2020
Figure 36. Global Nasopharyngeal Cancer Market Share Forecast by Application (2021-2026)
Figure 37. North America Nasopharyngeal Cancer Sales Market Share by Type (2016-2026)
Figure 38. North America Nasopharyngeal Cancer Sales Market Share by Application (2016-2026)
Figure 39. North America Nasopharyngeal Cancer Revenue Market Share by Country (2016-2026)
Figure 40. United States Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Nasopharyngeal Cancer Sales Market Share by Type (2016-2026)
Figure 44. Europe Nasopharyngeal Cancer Sales Market Share by Application (2016-2026)
Figure 45. Europe Nasopharyngeal Cancer Revenue Market Share by Country (2016-2026)
Figure 46. Germany Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Nasopharyngeal Cancer Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Nasopharyngeal Cancer Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Nasopharyngeal Cancer Revenue Market Share by Region (2016-2026)
Figure 54. China Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Nasopharyngeal Cancer Sales Market Share by Type (2016-2026)
Figure 61. South America Nasopharyngeal Cancer Sales Market Share by Application (2016-2026)
Figure 62. South America Nasopharyngeal Cancer Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Nasopharyngeal Cancer Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Nasopharyngeal Cancer Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Nasopharyngeal Cancer Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Nasopharyngeal Cancer Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
Buy
